Larry Biegelsen
Stock Analyst at Wells Fargo
(1.77)
# 1103
Out of 5,296 analysts
332
Total ratings
51.82%
Success rate
9.80%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PEN Penumbra | Maintains: Overweight | 305 315 | 298.38 | 5.57% | 18 | Apr 24, 2025 | |
RXST RxSight | Maintains: Equal-Weight | 22 17 | 14.69 | 15.72% | 12 | Apr 7, 2025 | |
KMTS Kestra Medical Techs | Initiates Coverage On: Overweight | 28 | 24.9 | 12.45% | 1 | Mar 31, 2025 | |
BLCO Bausch & Lomb | Downgrades: Equal-Weight | 24 15 | 13.82 | 8.54% | 5 | Mar 28, 2025 | |
HYPR Hyperfine | Maintains: Equal-Weight | 2 2 | 0.77 | 67.53% | 4 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 38 22 | 17.7 | 24.29% | 8 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 214 146 | 135.49 | 7.76% | 4 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 120 117 | 94.76 | 23.47% | 8 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 153 160 | 95.23 | 68.01% | 13 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 96 103 | 67.11 | 53.48% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 198 195 | 158.52 | 23.01% | 11 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 100 118 | 101.22 | 16.58% | 12 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 13 17 | 11.28 | 50.71% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 427 435 | 361.21 | 20.43% | 14 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 630 687 | 508.63 | 35.07% | 19 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 166 152 | 154.84 | -1.83% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 65 80 | n/a | n/a | 6 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 10 8 | 5.18 | 54.44% | 6 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 94 | 70.75 | 32.86% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 115 118 | 82.63 | 42.81% | 16 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 106 98 | 84.31 | 16.24% | 17 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 110 117 | 101.53 | 15.24% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 80 | 75.2 | 6.38% | 15 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 94 105 | 94.72 | 10.85% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 44 40 | 30.39 | 31.62% | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 42 40 | 18.51 | 116.1% | 17 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 17 14 | n/a | n/a | 11 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 200 210 | n/a | n/a | 6 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 68 71 | n/a | n/a | 6 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 40 49 | 16.75 | 192.54% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 140 136 | 129.46 | 5.05% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 80 70 | 73.11 | -4.25% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 62 | n/a | n/a | 6 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 279 270 | 204.47 | 32.05% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Apr 25, 2017 |